Zepp Health (ZEPP) Competitors $2.48 -0.02 (-0.80%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ZEPP vs. KOPN, ALOT, LTRX, SILC, INVE, MKFG, OSS, TACT, LINK, and QMCOShould you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include Kopin (KOPN), AstroNova (ALOT), Lantronix (LTRX), Silicom (SILC), Identiv (INVE), Markforged (MKFG), One Stop Systems (OSS), TransAct Technologies (TACT), Interlink Electronics (LINK), and Quantum (QMCO). These companies are all part of the "computer hardware" industry. Zepp Health vs. Kopin AstroNova Lantronix Silicom Identiv Markforged One Stop Systems TransAct Technologies Interlink Electronics Quantum Zepp Health (NYSE:ZEPP) and Kopin (NASDAQ:KOPN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment. Is ZEPP or KOPN more profitable? Zepp Health has a net margin of -19.24% compared to Kopin's net margin of -109.38%. Zepp Health's return on equity of -11.84% beat Kopin's return on equity.Company Net Margins Return on Equity Return on Assets Zepp Health-19.24% -11.84% -6.66% Kopin -109.38%-165.86%-42.90% Does the media prefer ZEPP or KOPN? In the previous week, Zepp Health had 2 more articles in the media than Kopin. MarketBeat recorded 7 mentions for Zepp Health and 5 mentions for Kopin. Kopin's average media sentiment score of 0.91 beat Zepp Health's score of 0.17 indicating that Kopin is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zepp Health 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Kopin 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ZEPP or KOPN? Zepp Health presently has a consensus price target of $20.76, indicating a potential upside of 737.10%. Kopin has a consensus price target of $2.67, indicating a potential upside of 164.03%. Given Zepp Health's higher probable upside, equities research analysts plainly believe Zepp Health is more favorable than Kopin.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zepp Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Kopin 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, ZEPP or KOPN? Zepp Health has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Kopin has a beta of 2.6, indicating that its stock price is 160% more volatile than the S&P 500. Does the MarketBeat Community believe in ZEPP or KOPN? Kopin received 304 more outperform votes than Zepp Health when rated by MarketBeat users. Likewise, 57.71% of users gave Kopin an outperform vote while only 50.00% of users gave Zepp Health an outperform vote. CompanyUnderperformOutperformZepp HealthOutperform Votes350.00% Underperform Votes350.00% KopinOutperform Votes30757.71% Underperform Votes22542.29% Which has preferable earnings and valuation, ZEPP or KOPN? Kopin has lower revenue, but higher earnings than Zepp Health. Kopin is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZepp Health$351.46M0.11-$29.88M-$2.50-0.99Kopin$44.27M2.76-$19.75M-$0.41-2.46 Do institutionals and insiders believe in ZEPP or KOPN? 52.6% of Zepp Health shares are held by institutional investors. Comparatively, 31.0% of Kopin shares are held by institutional investors. 36.0% of Zepp Health shares are held by company insiders. Comparatively, 6.7% of Kopin shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryZepp Health beats Kopin on 9 of the 17 factors compared between the two stocks. Ad Brownstone ResearchShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Click here for full details. Get Zepp Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZEPP vs. The Competition Export to ExcelMetricZepp HealthElectronic computers IndustryMedical SectorNYSE ExchangeMarket Cap$37.32M$451.06B$5.38B$20.14BDividend YieldN/A1.12%5.13%3.50%P/E Ratio-0.9927.02105.1444.57Price / Sales0.113.241,233.1517.74Price / CashN/A22.5840.4121.28Price / Book0.1111.027.094.71Net Income-$29.88M$12.30B$119.65M$986.85M7 Day Performance-19.74%9.14%2.25%3.76%1 Month Performance-28.94%-0.93%-2.33%4.65%1 Year Performance-44.14%22.30%33.98%27.72% Zepp Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZEPPZepp Health2.787 of 5 stars$2.48-0.8%$20.76+737.1%-46.6%$37.32M$351.46M-0.991,230News CoverageKOPNKopin3.272 of 5 stars$1.00+2.1%$2.67+168.0%-36.1%$117.97M$44.27M-2.43144Positive NewsGap UpALOTAstroNova1.5194 of 5 stars$15.00+3.2%N/A+5.7%$112.80M$148.09M17.31340LTRXLantronix3.336 of 5 stars$2.92+0.7%$6.50+122.6%-46.2%$112.33M$160.33M-20.71350Positive NewsSILCSilicom2.4068 of 5 stars$14.53+0.3%$20.00+37.6%-11.6%$98.22M$124.13M-4.84320INVEIdentiv3.5328 of 5 stars$3.95+1.3%$7.25+83.5%-42.9%$94.37M$116.38M1.29330News CoverageMKFGMarkforged2.3658 of 5 stars$4.40+4.0%$5.00+13.6%-45.2%$90.73M$93.78M-1.01370OSSOne Stop Systems2.5381 of 5 stars$2.44+4.7%$5.00+104.9%+13.7%$51.51M$60.90M-4.80110Gap UpTACTTransAct Technologies2.2519 of 5 stars$3.91-2.0%$7.50+91.8%-39.3%$39.14M$72.63M-19.55120Analyst ForecastLINKInterlink Electronics0.6249 of 5 stars$4.57-10.0%N/A-43.8%$29.62M$12.23M50.7890Gap DownQMCOQuantum0.9515 of 5 stars$4.02+33.1%$5.00+24.4%+49.2%$19.50M$311.60M0.00900Gap UpHigh Trading Volume Related Companies and Tools Related Companies Kopin Alternatives AstroNova Alternatives Lantronix Alternatives Silicom Alternatives Identiv Alternatives Markforged Alternatives One Stop Systems Alternatives TransAct Technologies Alternatives Interlink Electronics Alternatives Quantum Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ZEPP) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zepp Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zepp Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
